<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Manufacturing Process &#8211; Polypharma: Generics Developer</title>
	<atom:link href="https://polypharma.de/en/category/manufacturing-process/feed/" rel="self" type="application/rss+xml" />
	<link>https://polypharma.de</link>
	<description>Full-service in the production of generics and delivery of raw materials in Africa and the Middle East</description>
	<lastBuildDate>Wed, 29 Sep 2021 08:42:49 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://polypharma.de/wp-content/uploads/2020/07/cropped-Polypharma-Technologies-and-Sciences-Hamburg-150x150.png</url>
	<title>Manufacturing Process &#8211; Polypharma: Generics Developer</title>
	<link>https://polypharma.de</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Polypharma project planning for MENA pharma facilities</title>
		<link>https://polypharma.de/en/2021/08/polypharma-project-planning-for-mena-pharma-facilities/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Wed, 04 Aug 2021 12:00:57 +0000</pubDate>
				<category><![CDATA[Factory construction]]></category>
		<category><![CDATA[Manufacturing Process]]></category>
		<category><![CDATA[Pharmaceutical Raw Materials / Laboratory Equipment]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[biosimilar]]></category>
		<category><![CDATA[construction]]></category>
		<category><![CDATA[Consultant]]></category>
		<category><![CDATA[Developer]]></category>
		<category><![CDATA[DMF]]></category>
		<category><![CDATA[Dossier development]]></category>
		<category><![CDATA[drug]]></category>
		<category><![CDATA[Drug Master File]]></category>
		<category><![CDATA[factory planning]]></category>
		<category><![CDATA[generic manufacture]]></category>
		<category><![CDATA[generic pharma]]></category>
		<category><![CDATA[market opportunity analysis]]></category>
		<category><![CDATA[MENA]]></category>
		<category><![CDATA[MENA market]]></category>
		<category><![CDATA[MENA pharma facilities]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Polypharma]]></category>
		<category><![CDATA[project feasibility]]></category>
		<category><![CDATA[project planning]]></category>
		<category><![CDATA[project schedule]]></category>
		<category><![CDATA[project timeline]]></category>
		<category><![CDATA[raw material]]></category>
		<category><![CDATA[Sciences]]></category>
		<category><![CDATA[sourcing]]></category>
		<category><![CDATA[supply]]></category>
		<category><![CDATA[tech transfer]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[technology transfer]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=9079</guid>

					<description><![CDATA[Core competencies of Polypharma include project planning, feasibility studies, plant construction, technology transfer, pharmaceutical development, and materials sourcing and supply. Its full service offerings can include all these elements to provide a total solution for pharmaceutical developers and producers that can also include processing registrations, with on-site services that include all necessary API-manufacturer documentation, such as [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Polypharma celebrates 30th Anniversary</title>
		<link>https://polypharma.de/en/2021/06/polypharma-celebrates-30th-anniversary/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Fri, 18 Jun 2021 08:27:42 +0000</pubDate>
				<category><![CDATA[Counterfeit Medicines]]></category>
		<category><![CDATA[Development / Dossiers]]></category>
		<category><![CDATA[Factory construction]]></category>
		<category><![CDATA[Fairs / Events]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Manufacturing Process]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Pharmaceutical Raw Materials / Laboratory Equipment]]></category>
		<category><![CDATA[Registration Process]]></category>
		<category><![CDATA[30 years]]></category>
		<category><![CDATA[30th anniversary]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[biosimilar]]></category>
		<category><![CDATA[construction]]></category>
		<category><![CDATA[Consultant]]></category>
		<category><![CDATA[Developer]]></category>
		<category><![CDATA[Dossier development]]></category>
		<category><![CDATA[drug]]></category>
		<category><![CDATA[Drug Master File]]></category>
		<category><![CDATA[food supplements]]></category>
		<category><![CDATA[generic manufacture]]></category>
		<category><![CDATA[MENA]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Polypharma]]></category>
		<category><![CDATA[Polypharma tech]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[raw material]]></category>
		<category><![CDATA[Sciences]]></category>
		<category><![CDATA[sourcing]]></category>
		<category><![CDATA[supply]]></category>
		<category><![CDATA[Technologies]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=8650</guid>

					<description><![CDATA[Single partner Polypharma offers a unique blend of services and skills that make it possible for it to act as a single partner accompanying local companies all the way from selection of target product through to actual receipt of raw materials for production. “Over the years we have developed more than 200 approved drug dossiers [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Why Polypharma cannot recommend its partners to package purchased bulk medicines</title>
		<link>https://polypharma.de/en/2020/11/buying-bulk-medicines-not-recommended/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Mon, 16 Nov 2020 08:38:31 +0000</pubDate>
				<category><![CDATA[Manufacturing Process]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=9371</guid>

					<description><![CDATA[Many new customers find it interesting to pack already manufactured goods as a first step before producing their own medicines. Here are the reasons why Polypharma cannot recommend buying bulk medicines: From a pharmaceutical point of view, production and packaging in a GMP-compliant production line is the highest priority for the quality of the pharmaceuticals [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Formulations that enhance bioavailability</title>
		<link>https://polypharma.de/en/2020/08/formulations-that-enhance-bioavailability/</link>
		
		<dc:creator><![CDATA[Elidona Dalipaj]]></dc:creator>
		<pubDate>Tue, 25 Aug 2020 11:23:01 +0000</pubDate>
				<category><![CDATA[Manufacturing Process]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=7753</guid>

					<description><![CDATA[It is useful to combine in vitro testing and in silico modelling to predict and understand the in vivo performance of formulations that improve bioavailability, resulting in a successful in vivo test for belinostat. The key factor for in vivo performance was determined to be dissolution in the stomach prior to transit in the proximal [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Water Activity determination</title>
		<link>https://polypharma.de/en/2020/08/water-activity-determination/</link>
		
		<dc:creator><![CDATA[Elidona Dalipaj]]></dc:creator>
		<pubDate>Thu, 20 Aug 2020 11:20:04 +0000</pubDate>
				<category><![CDATA[Manufacturing Process]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=7747</guid>

					<description><![CDATA[Water activity (Aw) is a measure of the activity of free or unbound water that is available to participate in undesirable chemical, physical and biological reactions. Measurement of water activity at multiple time points during the product life cycle will be related to changes in critical quality attributes such as degradation of the active ingredient, [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>How To Address Challenges In Oncology Drug Containment / Polymer vials versus glass vials</title>
		<link>https://polypharma.de/en/2020/08/how-to-address-challenges-in-oncology-drug-containment-polymer-vials-versus-glass-vials/</link>
		
		<dc:creator><![CDATA[Elidona Dalipaj]]></dc:creator>
		<pubDate>Mon, 17 Aug 2020 11:03:23 +0000</pubDate>
				<category><![CDATA[Manufacturing Process]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=7734</guid>

					<description><![CDATA[The use of a polymer-based system reduces the risk of an undesirable chemical change in the drug product, or absorption of the drug product into the container, thereby reducing the dosage.]]></description>
		
		
		
			</item>
		<item>
		<title>Novel Analytical Techniques to Accelerate Biopharmaceutical Development</title>
		<link>https://polypharma.de/en/2020/08/novel-analytical-techniques-to-accelerate-biopharmaceutical-development/</link>
		
		<dc:creator><![CDATA[Elidona Dalipaj]]></dc:creator>
		<pubDate>Thu, 06 Aug 2020 10:51:22 +0000</pubDate>
				<category><![CDATA[Manufacturing Process]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=7721</guid>

					<description><![CDATA[Rapid and adaptable evaluation of monoclonal antibody therapeutics using the Fc receptor panel test based on Octet System before selection of the final molecule. The Octet system optimises itself for each new mAb, optimising the buffer and background conditions, thus minimising any non-specific interactions that might occur. Once this is done, it is necessary to [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Metal Detector for Tablets and Capsules</title>
		<link>https://polypharma.de/en/2020/07/metal-detector-for-tablets-and-capsules/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Sat, 11 Jul 2020 11:36:21 +0000</pubDate>
				<category><![CDATA[Manufacturing Process]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=6606</guid>

					<description><![CDATA[At first glance, metal detectors seem to be a good way to promote the safety of your own products. But is it an essential machine or a &#8220;nice to have&#8221;? The detectors are used to detect metal pieces e.g. of a sieve in a tablet/capsule that has torn during production and to sort them out. [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Nitrosamine Impurities</title>
		<link>https://polypharma.de/en/2020/07/nitrosamine-impurities/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Wed, 08 Jul 2020 11:33:02 +0000</pubDate>
				<category><![CDATA[Manufacturing Process]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=6602</guid>

					<description><![CDATA[In 2018, nitrosamine impurities were detected in the blood pressure medication of the Sartane group. Nitrosamines are potentially carcinogenic. Although the risk of these compounds being carcinogenic to humans is very low, the European Medicines Agency (EMA) has called for the holders of marketing authorisations for placing these raw materials on the EU market to [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>What you should know about pharmaceutical cleaning validation</title>
		<link>https://polypharma.de/en/2020/03/what-you-should-know-about-pharmaceutical-cleaning-validation/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Mon, 23 Mar 2020 10:56:25 +0000</pubDate>
				<category><![CDATA[Manufacturing Process]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=6556</guid>

					<description><![CDATA[Cleaning validation is a necessary and time-consuming part of the pharmaceutical manufacturing process. Cleaning validation is a requirement in pharmaceutical production that adheres to Good Manufacturing Practice (GMP) and Quality Systems Regulations (QSR). Simply put, validation is a documented guarantee that cleaning can be performed reliably and repeatedly to achieve a specified level of purity. [&#8230;]]]></description>
		
		
		
			</item>
	</channel>
</rss>
